en.Wedoany.com Reported - Diazyme Laboratories, Inc. announced the acquisition of the business of Carolina Liquid Chemistries Corporation (CLC). CLC is a U.S. Food and Drug Administration (FDA)-registered manufacturer and value-added distributor of chemistry systems and reagents, founded in 1994 and headquartered in Greensboro, North Carolina. Upon completion of this acquisition, CLC's operations will be integrated into Diazyme's operations.

Dr. Chong Yuan, Managing Director of Diazyme Laboratories, stated that CLC's cost-effective and reliable products will complement Diazyme's proprietary enzyme and immunoassay technologies, creating synergies that benefit laboratories of all sizes. This strategic acquisition will help enhance diagnostic capabilities, provide more comprehensive solutions for reference and clinical laboratories, and improve patient outcomes.

Diazyme Laboratories, Inc., located in Poway, California, leverages its proprietary enzyme and immunoassay technologies to develop diagnostic test reagents for automated chemistry analyzers and chemiluminescence instruments in a user-friendly format. The company is a cGMP and ISO 13485 certified medical device manufacturer.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com